Global X Genomics & Biotechnology ETF
GNOM
GNOM
63 hedge funds and large institutions have $124M invested in Global X Genomics & Biotechnology ETF in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% less capital invested
Capital invested by funds: $128M → $124M (-$3.82M)
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$20.7M | |
| 2 | +$795K | |
| 3 | +$479K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$329K |
| 5 |
MWAM
Manhattan West Asset Management
Los Angeles,
California
|
+$266K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$1.91M | |
| 3 | -$359K | |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
-$300K |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$79.5K |